JP2012500006A5 - - Google Patents

Info

Publication number

JP2012500006A5

JP2012500006A5 JP2011523095A JP2011523095A JP2012500006A5 JP 2012500006 A5 JP2012500006 A5 JP 2012500006A5 JP 2011523095 A JP2011523095 A JP 2011523095A JP 2011523095 A JP2011523095 A JP 2011523095A JP 2012500006 A5 JP2012500006 A5 JP 2012500006A5

Authority

JP

Japan

Prior art keywords

seq

variable region

chain variable

antibody

heavy chain

Prior art date

2009-08-11

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 125000003275 alpha amino acid group Chemical group 0.000 claims description 21
• 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims description 13
• 239000000427 antigen Substances 0.000 claims description 11
• 102000036639 antigens Human genes 0.000 claims description 11
• 108091007433 antigens Proteins 0.000 claims description 11
• 230000028993 immune response Effects 0.000 claims description 6
• 230000005867 T cell response Effects 0.000 claims description 4
• 206010028980 Neoplasm Diseases 0.000 claims description 2
• 238000004519 manufacturing process Methods 0.000 claims description 2
• 230000004614 tumor growth Effects 0.000 claims description 2
• 238000000034 method Methods 0.000 claims 5
• 210000004027 cell Anatomy 0.000 claims 3
• 230000004936 stimulating effect Effects 0.000 claims 3
• 102000017578 LAG3 Human genes 0.000 claims 2
• 101150030213 Lag3 gene Proteins 0.000 claims 2
• 208000036142 Viral infection Diseases 0.000 claims 2
• 239000013604 expression vector Substances 0.000 claims 2
• 102000039446 nucleic acids Human genes 0.000 claims 2
• 108020004707 nucleic acids Proteins 0.000 claims 2
• 150000007523 nucleic acids Chemical class 0.000 claims 2
• 230000009385 viral infection Effects 0.000 claims 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 241000282693 Cercopithecidae Species 0.000 claims 1
• 101001137986 Mus musculus Lymphocyte activation gene 3 protein Proteins 0.000 claims 1
• 210000001744 T-lymphocyte Anatomy 0.000 claims 1
• 239000003814 drug Substances 0.000 claims 1
• 239000003937 drug carrier Substances 0.000 claims 1
• 230000012010 growth Effects 0.000 claims 1
• 229940127121 immunoconjugate Drugs 0.000 claims 1
• 230000003308 immunostimulating effect Effects 0.000 claims 1
• 230000002401 inhibitory effect Effects 0.000 claims 1
• 229940124597 therapeutic agent Drugs 0.000 claims 1
• 210000004881 tumor cell Anatomy 0.000 claims 1
• 102000000588 Interleukin-2 Human genes 0.000 description 2
• 108010002350 Interleukin-2 Proteins 0.000 description 2
• 238000003364 immunohistochemistry Methods 0.000 description 2
• 230000001817 pituitary effect Effects 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 1
• 230000006023 anti-tumor response Effects 0.000 description 1
• 230000006472 autoimmune response Effects 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1